POLİFLEKS® Form Advantage

POLIFARMA offers its parenteral solution production in four different forms, as stated below:
  • PF Vacuumed Glass Bottle
  • Polypropylene (PP) Bottle
  • POLİFLEKS® Polypropylene (PP) bags
  • POLİFLEKS® Polyvinyl chloride (PVC) bags.

POLİFLEKS® Volume Advantage

POLIFARMA has been service the Turkish Medicine with the widest volume alternative in parenteral solution production as;
  • 50 ml
  • 500 ml
  • 1000 ml
  • 100 ml
  • 750 ml
  • 2000 ml
  • 150 ml
  • 850 ml
  • 3000 ml
  • 250 ml

PF Vacuumed Glass Parenteral Solutions

Polifarma, is producing vacuumed glass parenteral solutions since 1996 and has renewed its product portfolio and production technology for the last 19 years.

With its new production department which was modernised in 2011, Polifarma; has capacity of manufacturing 15 million units annually. Polifarma, by believeing the future of glass products, will continue its investments for this production line.

Irrigation Solutions

Polifarma, as the leader of the industry has a very extensive portfolio for Irrigation Solutions. Polifarma irrigation solutions which are being produced since 2011 in different packages and volumes in order to meet the necessity of different kind of irrigation.

POLİFLEKS® Polifleks Large and Small Volume Parenteral Solutions

POLİFLEKS, the registered trade mark of Polifarma that represents the PVC(polyvinyil chloride) and PP(polypropylene) bag products.

Producing POLİFLEKS polyvinyil chloride IV Solutions since 2002, Polifarma become the leader of the sector by investing manufacturing technology and product portfolio for large and small volume IV parenteral solutions. The capacity for producing polyvinyil chloride parenteral IV solution bags is 76 million annually.

Producing POLİFLEKS polypropylene IV Solutions since 2011, Polifarma has become the advantegous firm of the industry by producing the most extensive product portfolio. Especially Polifarma focuses for product safety and invested SFC Port System in 2014 for polypropylene IV parenteral solutions which are preferential for oncology drug appliances. Polifarma’s Polypropylene IV Solution line has the capacity of 17 million production annually and Polifarma continues to invest this department.


Polipropilen, is a thermoplastic polymer with a very wide area of usage in several fields. It is one of the lightest of thermoplastics. It has a very low ratio of being affected by organic composites. It can be melted and dissolved multiple times. Its code for international recycling is “5”. This holds a special meaning with regards to environmental protection. Thanks to its thermo stableness, thermal resistance and good resource features, health industry prefers polypropylene. The World Health Organization (WHO) considers the use of polypropylene (PP) in pharmaceutical packaging as useful. It has been observed in clinical studies that the drug solution behaviors in Polypropylene (PP) packaging are similar to those prepared in glass packaging.

The melting point of polypropylene is between 130 ºC - 171 ºC. It is resistant to heat; therefore parenteral solutions with polypropylene packaging can be sterilized at 121 ºC by means of autoclaving method without the need for a secondary packaging.

Polypropylene has high tolerance against chemical solvents (such as acid and bases). There is no transition of chemical substances between the inner surface of the pocket and the solution. The fact that there is no drug-pocket interaction renders drug concentration stable. Therefore, the patient fully receives the drug that is added into the solution.

Because the water and steam permeability of polypropylene is at a minimum level, the concentration of the solution does not change due to storing over time. In this manner, the drug/solution can be securely stocked up for longer periods of time.

Read More

POLİSET® Infusion sets

POLİ-SET® the registered trade mark of Polifarma that represents single use Basic Infusions Sets.

Polifarma; the leader of producing large and small volume parenteral solutions, has the capacity of 39 million units production capacity of POLI-SET infusion sets wich are being used with our solutions.